Neumora Therapeutics, Inc. — Director's Dealing 2026

Jan 9, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neumora Therapeutics, Inc. (NMRA)
CIK: 0001885522
Period of Report: 2026-01-08

Reporting Person: BERNS PAUL L (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-08	Stock Option (Right to Buy)	$2.33	A	1650000	Acquired	2036-01-08	Common Stock (1650000)	Direct

Footnotes

F1: 25% of the shares subject to the option vest on the first anniversary measured from January 8, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.